An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes

Immunology and Cell Biology

Volumn 82, Issue 4, 2004, Pages 427-434

  Amirahmadi, S Fatemah ^a   Minh, Hue Pho ^a   Gray, Robyn E ^a   Crombie, Duncan E ^a   Whittingham, Senga F ^a   Zuasti, Beltzane Biurrun ^a   Van Damme, Marie Paule ^a   Rowley, Merrill J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Arthritis; Cartilage formation; Chondrocytes; CII C1; Collagen antibodies

Indexed keywords

COLLAGEN; COLLAGEN FIBRIL; COLLAGEN TYPE 2 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; PROLINE; PROTEOGLYCAN; SULFATE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARTILAGE; CARTILAGE CELL; CELL ASSAY; CELL CULTURE; CELL LABELING; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CULTURE MEDIUM; DEGRADATION; DENSITY; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; HYPOTHESIS; IN VITRO STUDY; INHIBITION KINETICS; METABOLISM; MICROSCOPY; MOLECULE; NONHUMAN; REACTION ANALYSIS; STRUCTURE ANALYSIS; SYNTHESIS; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, EXPERIMENTAL; CARTILAGE; CATTLE; CELL CULTURE TECHNIQUES; CELL-FREE SYSTEM; CHONDROCYTES; COLLAGEN TYPE II; MATRIX METALLOPROTEINASE 2; MICE; PROTEOGLYCANS; RECEPTORS, FC;

ANIMALIA; BOVINAE; TRITIUM;

EID: 4344584784     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0818-9641.2004.01267.x     Document Type: Article

References (30)

1. Brand DD, Marion TN, Myers LK et al. Autoantibodies to murine type II collagen in collagen-induced arthritis: a comparison of susceptible and nonsusceptible strains. J. Immunol. 1996; 157: 5178-84.
2. Burkhardt H, Koller T, Engstrom A et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum. 2002; 46: 2339-48.
3. Nandakumar KS, Andren M, Martinsson P et al. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. Eur J. Immunol. 2003; 33: 2269-77.
4. Schulte S, Unger C, Mo JA et al. Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J. Biol. Chem. 1998; 273: 1551-61.
5. Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum. 1986; 29: 400-10.
6. Burkhardt H, Holmdahl R, Deutzmann R, Wiedemann H et al. Identification of a major antigenic epitope on CNBr.-fragment 11 of type II collagen recognized by murine autoreactive B cells. Eur. J. Immunol. 1991; 21: 49-54.
7. Chang YC, Gottlieb DI. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J. Neurosci. 1988; 8: 2123-30.
8. Cook AD, Davies JM, Myers MA, Mackay IR, Rowley MJ. Mimotopes identified by phage display for the monoclonal antibody CII-C1 to type II collagen. J. Autoimmun. 1998; 11: 205-11.
9. Davies JM, Rowley MJ, MacKay IR. Phagotopes derived by antibody screening of phage-displayed random peptide libraries vary in immunoreactivity: studies using an exemplary monoclonal antibody, CII-C1, to type II collagen. Immunol. Cell Biol. 1999; 77: 483-90.
10. Van Damme MP, Sinnaya P, Derry K, Murphy WH, Preston BN. Temporal changes in charge content of cultured chondrocytes from bovine cartilaginous tissues. Matrix Biol. 1997; 15: 495-502.
11. Chan D, Taylor TK, Cole WG. Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia. J. Biol. Chem. 1993; 268: 15238-45.
12. Bonner WM, Laskey RA. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur. J. Biochem. 1974; 46: 83-8.
13. Rowley M, Tait B, Mackay IR, Cunningham T, Phillips B. Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum. 1986; 29: 174-84.
14. Rawdanowicz TJ, Hampton AL, Nagase H, Woolley DE, Salamonsen LA. Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J. Clin. Endocrinol. Metab. 1994; 79: 530-6.
15. Miyahara M, Hayashi K, Berger J et al. Formation of collagen fibrils by enzymic cleavage of precursors of type I collagen in vitro. J. Biol. Chem. 1984; 259: 9891-8.
16. Gregory KE, Marsden ME, Anderson-MacKenzie J et al. Abnormal collagen assembly, though normal phenotype, in alginate bead cultures of chick embryo chondrocytes. Exp. Cell Res. 1999; 246: 98-107.
17. Muir H. The chondrocyte, architect of cartilage: biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 1995; 17: 1039-48.
18. Urban JP, Hall AC, Gehl KA. Regulation of matrix synthesis rates by the ionic and osmotic environment of articular chondrocytes. J. Cell Physiol. 1993; 154: 262-70.
19. Oakes BW, Handley CJ, Lisner F, Lowther DA. An ultrastructural and biochemical study of high density primary cultures of embryonic chick chondrocytes. J. Embryol Exp. Morph. 1977; 38: 239-63.
20. Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 1985; 28: 241-8.
21. Hogarth PM. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr. Opin. Immunol. 2002; 14: 798-802.
22. Saura R, Uno K, Satsuma S, Kurz EU, Scudamore RA, Cooke TD. Mechanisms of cartilage degradation in inflammatory arthritis: interaction between chondrocytes and immunoglobulin G. J. Rheumatol. 1993; 20: 336-43.
23. Takagi T, Jasin HE. Interactions between anticollagen antibodies and chondrocytes. Arthritis Rheum. 1992; 35: 224-30.
24. Takagi T, Jasin HE. Interactions of synovial fluid immunoglobulins with chondrocytes. Arthritis Rheum. 1992; 35: 1502-9.
25. Brodsky B, Shah NK. Protein motifs. 8. The triple-helix motif in proteins. FASEB J. 1995; 9: 1537-46.
26. Williams BR, Gelman RA, Poppke DC, Piez KA. Collagen fibril formation. Optimal in vitro conditions and preliminary kinetic results. J. Biol. Chem. 1978; 253: 6578-85.
27. Kimura H, Tateishi H, Ziff M. Surface ultrastructure of rheumatoid articular cartilage. Arthritis Rheum. 1977; 20: 1085-94.
28. Cenacchi G, Carrabba M, Govoni E, Angelini M, Colombo B, Laschi R. The possible role of collagen fibril dysplasia in the pathogenesis of cartilage damage in rheumatoid arthritis. Clin. Exp. Rheumatol. 1987; 5: 189-90.
29. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat. Rev. Immunol. 2002; 2: 364-71.
30. Klareskog L, van der Heijde D, de Jager JP et al. Therapeutic effect of the combination of etanercept and metotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 2004; 363: 675-81.